News
8.10.20

Interview with Reto Naef, CEO of TOPADUR PHARMA AG

7.9.23
News

TOPADUR has been selected as a TOP 100 Scale-up 2023 with unicorn potential

We are proud to be recognized as one of Switzerland's most promising scale-ups in 2023.

Read more
8.9.22
News

TOPADUR has been selected as a TOP 100 Scale-up 2022 with unicorn potential

We are proud to be recognized as one of Switzerland's most promising scale-ups in 2022.

Read more
5.1.24
Press Release

Topadur Pharma AG receives an innosuisse grant

CHF 1.76 million is awarded from Innosuisse for the Phase 2a clinical trial with TOP-N53 in the treatment of digital ulcers

Read more